{"CACHEDAT":"2026-05-14 20:30:22","TRANSLATEDAT":"2026-05-14 20:30:22","SOURCESIGNATURE":"b0f9698ac72347dfa0ac40ef96cd252cd75f5d96049901a2b51ba12a8da0a70c","SLUG":"designer-babies-and-ethical-controversies-RhIcqcexBc","MARKDOWN":"# Controversy\n\n## Key Debate\n\n**Should humans use gene‐editing and embryo selection to design babies with preferred traits — and if so, who decides which traits and on what basis?**\\n→ [https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/](https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/?utm_source=chatgpt.com) [petrieflom.law.harvard.edu](https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/?utm_source=chatgpt.com)\\n→ [https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com) [genome.gov](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com)\n\n## Main Viewpoints\n\n* **Therapeutic use only** — Gene editing should be limited to preventing serious genetic diseases, not enhancing traits.\\n→ [https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/?utm_source=chatgpt.com)\n* **Enhancement and freedom of choice** — Parents should have the autonomy to choose traits, and technology is natural progression.\\n→ [https://www.theguardian.com/science/2017/jan/08/designer-babies-ethical-horror-waiting-to-happen](https://www.theguardian.com/science/2017/jan/08/designer-babies-ethical-horror-waiting-to-happen?utm_source=chatgpt.com) [theguardian.com](https://www.theguardian.com/science/2017/jan/08/designer-babies-ethical-horror-waiting-to-happen?utm_source=chatgpt.com)\n* **Regulatory caution with justice focus** — Without strict oversight, designer‑baby technologies risk reinforcing inequality and eugenics.\\n→ [https://www.heritage.org/marriage-and-family/commentary/just-because-we-can-create-genetically-modified-babies-doesnt-meanThe Heritage Foundation](https://www.heritage.org/marriage-and-family/commentary/just-because-we-can-create-genetically-modified-babies-doesnt-mean?utm_source=chatgpt.com)\n* **Cultural/spiritual objection** — Some view the manipulation of embryos as \"playing God,\" violating natural or divine order.\\n→ [https://embryo.asu.edu/pages/ethics-designer-babiesembryo.asu.edu](https://embryo.asu.edu/pages/ethics-designer-babies?utm_source=chatgpt.com)\n\n\n---\n\n# Scientific Dimension\n\n## Core Scientific Facts\n\n* **Germline editing makes changes inheritable by future generations**, raising unique risks and ethical issues.\\n→ [https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concernsgenome.gov](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com)\n* **CRISPR and other gene‑editing tools now enable precise changes in embryos**, though off‑target effects and mosaicism remain major challenges.\\n→ [https://pmc.ncbi.nlm.nih.gov/articles/PMC6342697/pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6342697/?utm_source=chatgpt.com)\n* **Technologies are advancing faster than regulatory frameworks** — many countries lack harmonised law for embryo editing and trait selection.\\n→ [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/?utm_source=chatgpt.com)\n\n## Domains of Expertise\n\n* **Genetics & Developmental Biology**\n * Embryonic development, gene regulation\n * Editing mechanisms (CRISPR/Cas9), off‑target risk\n* **Bioethics & Philosophy**\n * Autonomy, consent, human dignity\n * Enhancement vs therapy, justice in access\n* **Law & Governance**\n * International regulation, human subject protection\n * Assisted‑reproductive technologies law\n* **Sociology & Anthropology**\n * Cultural attitudes to genetic intervention\n * Societal stratification and inequality\n* **Technology & Data Ethics**\n * AI in embryo selection, data privacy\n * Algorithmic bias in genetic trait prediction\n\n\n---\n\n# Main Drivers Behind the Issue\n\n* **Rapid biotechnological innovation** — gene editing tools are more accessible and powerful.\n* **Desire to prevent or eliminate genetic disease** — a strong motivating factor for embryo interventions.\n* **Consumerist and enhancement culture** — increasing interest in non‑therapeutic trait selection (intelligence, height, appearance).\n* **Regulatory and ethical lag** — technology outpaces law, leading to global inconsistency and \"genetic tourism.\"\n* **Global inequality** — Access to advanced reproductive genetics is often restricted by wealth and geography, risking new forms of genetic stratification.\\n→ [petrieflom.law.harvard.edu](https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/?utm_source=chatgpt.com)\\n→ [genome.gov](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com)\n\n\n---\n\n# Common Misrepresentations and Misperceptions\n\n## Commonly Misunderstood Figures (Percentages, Risks, Probabilities)\n\n| Misunderstood Figure | Clarification or Explanation |\n|----------------------|------------------------------|\n| **\"Designer babies are already widespread.\"**
→ [embryo.asu.edu](https://embryo.asu.edu/pages/ethics-designer-babies?utm_source=chatgpt.com) | Germline editing in humans is rare, heavily regulated, often experimental. |\n| **\"Selecting traits like intelligence is simple and well‑understood.\"**
→ [genome.gov](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com) | Many traits are polygenic, complex and poorly predicted — selection is very uncertain. |\n\n## Common Misconceptions\n\n| Misconception | Correction |\n|---------------|------------|\n| **\"Gene editing only benefits the child.\"**
→ | Interventions affect families, societies, future generations and can widen inequality. |\n| **\"Therapy and enhancement are clearly separate.\"**
→ [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/?utm_source=chatgpt.com) | The line between curing disease and improving traits is blurry and contested. |\n\n## Common Misinformation\n\n| Misinformation | Correction or Clarification |\n|----------------|-----------------------------|\n| **\"Genetically‑edited babies are already walking around with super‑traits.\"**
→ [pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6342697/?utm_source=chatgpt.com) | No verified case of intentional trait‑enhanced babies with known results and broad ethical oversight. |\n| **\"Editing embryos is entirely safe and risk‑free.\"**
→ [genome.gov](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com) | Significant risks remain — mosaicism, unintended edits, long‑term unknowns. |\n\n\n---\n\n# Parties Affected\n\n## by Impacts\n\n| Impact | Positively Affected (Individual) | Positively Affected (Organisational / Industrial) | Positively Affected (Societal) | Negatively Affected (Individual) | Negatively Affected (Organisational / Industrial) | Negatively Affected (Societal) |\n|--------|----------------------------------|---------------------------------------------------|--------------------------------|----------------------------------|---------------------------------------------------|--------------------------------|\n| Use of gene editing to avoid hereditary disease | Parents of at‐risk couples | Fertility/biotech firms | Reduced disease burden | Children with unforeseen effects | Clinics facing stigma | Genetic inequality emerges |\n| Designer trait selection in children | Wealthy prospective parents | High‐end fertility services | Enhanced talent pools (?), innovation | Children under trait pressure | Traditional clinics lose business | Social stratification by genome |\n\n## by Potential Solutions\n\n| Potential Solution | Positively Affected (Individual) | Positively Affected (Organisational / Industrial) | Positively Affected (Societal) | Negatively Affected (Individual) | Negatively Affected (Organisational / Industrial) | Negatively Affected (Societal) |\n|--------------------|----------------------------------|---------------------------------------------------|--------------------------------|----------------------------------|---------------------------------------------------|--------------------------------|\n| Global regulation & moratorium on non‑therapeutic germline editing | At‐risk families reassured | Licensed clinics, regulated biotech | Equity in access and safety | Unregulated DIY markets may persist | Unlicensed clinics lose profits | Slower adoption of technology |\n| Public education + equitable access programs | Informed future parents | Non‑profit reproductive health orgs | Fairer genetics outcomes | Wealthy parents may seek alternatives | Private luxury genetic markets shrink | Genetic \"divide\" reduced |\n\n\n---\n\n# Trade‑off Analysis\n\n## Autonomy vs. Collective Justice\n\n* **Parents' freedom to choose traits vs. risk of societal stratification.**\n * Balancing individual desires with fairness and equality.\n\n## Innovation vs. Precaution\n\n* **Rapid biotech advancement vs. unknown long‑term effects and moral concerns.**\n * How much risk is acceptable for conceivable benefit?\n\n## Therapy vs. Enhancement\n\n* **Eradicating disease vs. enhancing normal traits.**\n * What counts as necessary therapy and what counts as \"luxury\" change?\n\n\n---\n\n# Guided Self‑Reflection Prompts\n\n* **What values influence your attitude toward genetic choice in children?**\n * Health, fairness, uniqueness, freedom?\n* **Would you want to select traits for your future children? Why or why not?**\n * Which traits might matter to you?\n* **How would you feel if your child was selected for traits you chose?**\n * Pressures, identity issues, natural development?\n* **What responsible uses of reproductive genetics do you accept — and what do you reject?**\n * Disease prevention acceptable? Trait choosing not?\n* **What trade‑offs are you willing (or not willing) to make for genetic choice?**\n * Cost, regulation, equality, long‐term unknowns?\n\n\n---\n\n# Curricular Connections → Classroom Topics\n\n* **Biology (15–18)**\n * Gene editing, germline vs somatic, CRISPR mechanisms\n* **Ethics / Philosophy (16+)**\n * Autonomy, human enhancement, eugenics\n* **Religious Education / Cultural Studies (14–17)**\n * Views on \"playing God\", nature of life, dignity\n* **Civics / Social Studies (14–18)**\n * Regulation of biotechnology, inequality, global governance\n* **Media Literacy (12–18)**\n * Interpreting claims about \"designer babies\", science vs hype\n\n\n---\n\n# Further Reading and Exploration\n\n* [https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/](https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/?utm_source=chatgpt.com)\n* [https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns](https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns?utm_source=chatgpt.com)\n* [https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6733984/?utm_source=chatgpt.com)\n* [https://www.heritage.org/marriage-and-family/commentary/just-because-we-can-create-genetically-modified-babies-doesnt-mean](https://www.heritage.org/marriage-and-family/commentary/just-because-we-can-create-genetically-modified-babies-doesnt-mean?utm_source=chatgpt.com)","HTML":"

Kontroverza

\n

Ključna razprava

\n

Ali naj ljudje uporabljajo urejanje genov in izbor zarodkov za ustvarjanje otrok z želenimi lastnostmi – in če da, kdo odloča, katere lastnosti in na kakšni podlagi?
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">https://petrieflom.law.harvard.edu/2024/03/11/designer-babies-the-ethical-and-regulatory-implications-of-polygenic-embryo-screening/source=chatgpt.com\" target=\"blank\" rel=\"noopener\">petrieflom.law.harvard.edu
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">https://www.genome.gov/about-genomics/policy-issues/Genome-Editing/ethical-concerns source=chatgpt.com\" target=\"blank\" rel=\"noopener\">genome.gov

\n

Glavna stališča

\n\n
\n

Znanstvena razsežnost

\n

Osnovna znanstvena dejstva

\n\n

Področja strokovnega znanja

\n\n
\n

Glavni dejavniki, ki vplivajo na to vprašanje

\n\n
\n

Pogoste napačne predstavitve in napačna dojemanja

\n

Pogosto napačno razumljene številke (odstotki, tveganja, verjetnosti)

\n\n\n\n\n\n\n\n\n\n\n\n\n
Napačno razumljena številkaPojasnilo ali razlaga
„Dizajnerski otroci so že zelo razširjeni.“
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">embryo.asu.edu		Urejanje zarodne linije pri ljudeh je redko, strogo regulirano in pogosto eksperimentalno.
»Izbiranje lastnosti, kot je inteligenca, je preprosto in dobro razumljivo.«
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">genome.gov		Mnoge lastnosti so poligenske, kompleksne in težko predvidljive – izbira je zelo negotova.
\n

Pogosta napačna prepričanja

\n\n\n\n\n\n\n\n\n\n\n\n\n
ZmotaPopravek
»Urejanje genov koristi le otroku.«
→ https://www.heritage.org/marriage-and-family/commentary/just-because-we-can-create-genetically-modified-babies-doesnt-mean		Posegi vplivajo na družine, družbe, prihodnje generacije in lahko povečajo neenakost.
»Terapija in izboljševanje sta jasno ločena.«
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">pmc.ncbi.nlm.nih.gov		Meja med zdravljenjem bolezni in izboljševanjem lastnosti je nejasna in sporna.
\n

Pogoste napačne informacije

\n\n\n\n\n\n\n\n\n\n\n\n\n
Napačne informacijePopravek ali pojasnilo
»Genetsko spremenjeni dojenčki že hodijo naokrog s super lastnostmi.«
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">pmc.ncbi.nlm.nih.gov		Ni nobenega potrjenega primera namerno genetsko spremenjenih dojenčkov z znanimi rezultati in širokim etičnim nadzorom.
»Urejanje zarodkov je popolnoma varno in brez tveganja.«
→ source=chatgpt.com\" target=\"blank\" rel=\"noopener\">genome.gov		Ostajajo znatna tveganja – mozaicizem, nenamerne spremembe, dolgoročne neznanke.
\n
\n

Prizadete strani

\n

zaradi vplivov

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
VplivPozitivno prizadete (posamezniki)Pozitivno prizadete (organizacije / industrija)Pozitivno prizadete (družbeno)Negativno vplivani (posamezniki)Negativni vpliv (organizacijski / industrijski)Negativno vpliva (družbeno)
Uporaba urejanja genov za preprečevanje dednih bolezniStarši ogroženih parovPodjetja za plodnost/biotehnologijoZmanjšanje bremena bolezniOtroci z nepredvidljivimi učinkiKlinike, ki se soočajo s stigmatizacijoPojav genetske neenakosti
Izbiranje želenih lastnosti pri otrocihPremožni bodoči staršiVrhunske storitve na področju plodnostiVečji bazen talentov (?), inovacijeOtroci pod pritiskom lastnostiTradicionalne klinike izgubljajo poselSocialna stratifikacija po genomu
\n

po potencialnih rešitvah

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Možna rešitevPozitivno vpliva (posameznik)Pozitivno vpliva (organizacijsko / industrijsko)Pozitivno vplivani (družbeno)Negativno vplivani (posameznik)Negativno vpliva (organizacijsko / industrijsko)Negativno vplivani (družbeno)
Globalna ureditev in moratorij na neterapevtsko urejanje zarodne linijePomiritev ogroženih družinLicencirane klinike, regulirana biotehnologijaEnakopravnost pri dostopu in varnostiNeregulirani trgi za samostojno izvajanje postopkov se lahko ohranijoNelicencirane klinike izgubijo dobičekPočasnejše uvajanje tehnologije
Izobraževanje javnosti + programi za enakopraven dostopObveščeni bodoči staršiNepridobitne organizacije za reproduktivno zdravjePravičnejši genetski izidiPremožni starši bodo morda iskali alternativeZmanjšanje zasebnih trgov z luksuznimi genetskimi storitvamiZmanjšanje genetske „vrzeli“
\n
\n

Analiza kompromisov

\n

Avtonomija proti kolektivni pravičnosti

\n\n

Inovacije proti previdnosti

\n\n

Terapija proti izboljšanju

\n\n
\n

Vodeni spodbudi za samorefleksijo

\n\n
\n

Povezave s kurikulumom → Teme za pouk

\n\n
\n

Dodatno branje in raziskovanje

\n","UPDATEDAT":"2026-05-11T20:22:59.765Z","LANG":"sl","ID":"d29eb225-4234-4076-9fdf-112797aace48","TITLE":"Otroci po meri in etične dileme","SOURCELANG":"en"}